Search Results

The SEC has no rule regarding the charges against the Citron Research founder. Now Left is challenging the commission to come up with one.

Michael Barry will oversee the Baltimore-based university’s $13B endowment.

Healthcare stocks have been hard hit by RFK Jr.’s nomination to head HHS.

Trump’s attempts to buy the island from Denmark have been rebuffed by locals but could have lasting impact for investors.

Yannick Beaudoin will succeed Charbonneau as president and CEO of PSP’s investment arm.

Richard Ennis argues that portfolio construction has become almost primitive. “Institutions own a jumble of equity things — nearly countless, largely illiquid, and beyond their control.”

The spectacular gains made the fund a top performer in 2024.

“Now we have an industry with a history of flouting regulation mixing in with traditional financial services. What could go wrong?”

Palmer enhanced returns by internally managing 20 percent of public market assets and starting a co-investment program for private markets.

Another European chemicals company now ranks among the firm’s five largest long positions.